Immatics Biotechnologies Gmbh Stock Price on December 3, 2024
| IMTXW Stock | USD 0.34 0.08 19.05% |
Below is the normalized historical share price chart for immatics biotechnologies GmbH extending back to July 02, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Immatics Biotechnologies stands at 0.34, as last reported on the 11th of December 2024, with the highest price reaching 0.42 and the lowest price hitting 0.34 during the day.
If you're considering investing in Immatics Stock, it is important to understand the factors that can impact its price. Immatics Biotechnologies holds Efficiency (Sharpe) Ratio of -0.26, which attests that the entity had a -0.26% return per unit of risk over the last 3 months. Immatics Biotechnologies exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immatics Biotechnologies' Standard Deviation of 11.16, risk adjusted performance of (0.13), and Market Risk Adjusted Performance of 1.04 to validate the risk estimate we provide.
Common Stock Shares Outstanding is likely to drop to about 70.8 M in 2024. Total Stockholder Equity is likely to drop to about 115.4 M in 2024. At this time, Immatics Biotechnologies' Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to climb to 0.03 in 2024, whereas Price Earnings Ratio is likely to drop (8.31) in 2024. Immatics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of July 2020 | Beta 0.776 |
Immatics |
Sharpe Ratio = -0.2643
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IMTXW |
Estimated Market Risk
| 11.61 actual daily | 96 96% of assets are less volatile |
Expected Return
| -3.07 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.26 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Immatics Biotechnologies is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immatics Biotechnologies by adding Immatics Biotechnologies to a well-diversified portfolio.
Book Value 2.659 | Shares Float 62.5 M | Market Capitalization 673 M | Shares Short Prior Month 736 | Shares Short 931 |
Immatics Biotechnologies Main Headline on 3rd of December 2024
Immatics Short Interest Update by thelincolnianonline.com
Immatics was the recipient of a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 900 shares, an increase of 28.6 percent from the October 31st total of 700 shares. Based on an average daily trading volume, of 17,800 shares, the
Immatics Biotechnologies Valuation on December 3, 2024
It is possible to determine the worth of Immatics Biotechnologies on a given historical date. On December 3, 2024 Immatics was worth 0.42 at the beginning of the trading date compared to the closed value of 0.39. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Immatics Biotechnologies stock. Still, in general, we apply an absolute valuation method to find Immatics Biotechnologies' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Immatics Biotechnologies where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Immatics Biotechnologies' related companies.
| Open | High | Low | Close | Volume | |
| 0.51 | 0.51 | 0.40 | 0.40 | 959,269 | |
12/03/2024 | 0.42 | 0.42 | 0.39 | 0.39 | 502.00 |
| 0.40 | 0.40 | 0.40 | 0.40 | 200.00 |
| Backtest Immatics Biotechnologies | | | Immatics Biotechnologies History | | | Immatics Biotechnologies Valuation | Previous | Next |
Immatics Biotechnologies Trading Date Momentum on December 3, 2024
| On December 04 2024 immatics biotechnologies GmbH was traded for 0.40 at the closing time. The highest daily price throughout the period was 0.40 and the lowest price was 0.40 . The daily volume was 200. The net trading volume on 12/04/2024 added to the next day price increase. The trading delta at closing time to closing price of the next trading day was 2.56% . The trading date delta to current closing price is 2.56% . |
Immatics Biotechnologies Fundamentals Correlations and Trends
By evaluating Immatics Biotechnologies' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Immatics Biotechnologies' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Immatics financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Immatics Biotechnologies Stock history
Immatics Biotechnologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immatics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immatics Biotechnologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immatics Biotechnologies stock prices may prove useful in developing a viable investing in Immatics Biotechnologies
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 80.5 M | 70.8 M |
Immatics Biotechnologies Quarterly Net Working Capital |
|
Immatics Biotechnologies Stock Technical Analysis
Immatics Biotechnologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Immatics Biotechnologies Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
immatics biotechnologies GmbH cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Immatics Biotechnologies December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Immatics Biotechnologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immatics Biotechnologies shares will generate the highest return on investment. By undertsting and applying Immatics Biotechnologies stock market strength indicators, traders can identify immatics biotechnologies GmbH entry and exit signals to maximize returns
Immatics Biotechnologies Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Immatics Biotechnologies' price direction in advance. Along with the technical and fundamental analysis of Immatics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immatics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (1.90) | |||
| Total Risk Alpha | (3.91) | |||
| Treynor Ratio | 1.03 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Immatics Stock Analysis
When running Immatics Biotechnologies' price analysis, check to measure Immatics Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics Biotechnologies is operating at the current time. Most of Immatics Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Immatics Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics Biotechnologies' price. Additionally, you may evaluate how the addition of Immatics Biotechnologies to your portfolios can decrease your overall portfolio volatility.